Literature DB >> 6543698

Concomitant development of granulocytosis and enhancement of metastases formation in tumor-bearing mice.

L Milas, M H Faykus, W H McBride, N Hunter, L J Peters.   

Abstract

The experiments reported here show concomitant development of granulocytosis and enhancement of metastasis formation in C3Hf/Kam mice bearing NFSA fibrosarcoma. Both phenomena developed at approximately 2 weeks after s.c. transplantation of tumor cells, at a time when the tumor was approximately 10 mm in diameter. The number of granulocytes in the blood doubled approximately every 3.5 days, reaching about 30 times control levels shortly before the death of the mice. The magnitude of the metastasis enhancement formation by i.v. injection of tumor cells was three to four times the control value. Mice bearing NFSA had a significant increase in the number of endogenous CFUs. Plasma from NFSA-bearing mice and medium from cultured NFSA cells stimulated in vitro growth of granulocyte and macrophage colonies from normal bone marrow cell precursors, and induced granulocytosis upon i.v. injection into normal mice. This shows that NFSA tumor secretes factor(s) with potent granulopoietic activity. Injection of plasma from tumor-bearing animals followed by i.v. injection of NFSA cells did not lead to the enhancement of metastasis, implying that granulocytosis might be rather concomitant manifestation than a causative factor of the enhancement of metastasis formation. Importance of granulocytosis as a paraneoplastic manifestation during tumor growth is discussed.

Entities:  

Mesh:

Year:  1984        PMID: 6543698     DOI: 10.1007/bf00132924

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  7 in total

1.  Stimulated granulocytopoiesis in mice bearing fibrosarcoma.

Authors:  L Milas; I Basic
Journal:  Eur J Cancer       Date:  1972-06       Impact factor: 9.162

2.  Delayed hematological recovery after cyclophosphamide treatment in the presence of an advanced tumor.

Authors:  W D DeWys; J M Mansky
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

3.  Immune stimulation-inhibition of experimental cancer metastasis.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1974-03       Impact factor: 12.701

4.  Hemopoietic stem cell kinetics in mice bearing CSF-producing fibrosarcoma.

Authors:  M Bessho; K Hirashima; K Ando; N Nara; H Momoi
Journal:  Nihon Ketsueki Gakkai Zasshi       Date:  1984-02

5.  Depletion of lymphocyte subpopulations in primary and secondary lymphoid organs of mice by a transplanted granulocytosis-inducing mammary carcinoma.

Authors:  M Y Lee; C Rosse
Journal:  Cancer Res       Date:  1982-04       Impact factor: 12.701

6.  High proliferation of granulocyte-macrophage progenitors in tumor-bearing mice.

Authors:  L Balducci; C Hardy
Journal:  Cancer Res       Date:  1983-10       Impact factor: 12.701

7.  GRANULOCYTOSIS-PROMOTING EXTRACT OF MOUSE TUMOR TISSUE: PARTIAL PURIFICATION.

Authors:  L DELMONTE; R A LIEBELT
Journal:  Science       Date:  1965-04-23       Impact factor: 47.728

  7 in total
  6 in total

1.  The host environment promotes the development of primary and metastatic squamous cell carcinomas that constitutively express proinflammatory cytokines IL-1alpha, IL-6, GM-CSF, and KC.

Authors:  C W Smith; Z Chen; G Dong; E Loukinova; M Y Pegram; L Nicholas-Figueroa; C Van Waes
Journal:  Clin Exp Metastasis       Date:  1998-10       Impact factor: 5.150

2.  Proportion of infiltrating IgG-binding immune cells predict for tumour hypoxia.

Authors:  D R Collingridge; S A Hill; D J Chaplin
Journal:  Br J Cancer       Date:  2001-03-02       Impact factor: 7.640

Review 3.  A Century of Radiation Therapy and Adaptive Immunity.

Authors:  Dörthe Schaue
Journal:  Front Immunol       Date:  2017-04-11       Impact factor: 7.561

4.  Colony-stimulating activity from the new metastatic TS/A cell line and its high- and low-metastatic clonal derivatives.

Authors:  G Nicoletti; P Brambilla; C De Giovanni; P L Lollini; B Del Re; A Marocchi; P Mocarelli; G Prodi; P Nanni
Journal:  Br J Cancer       Date:  1985-08       Impact factor: 7.640

5.  Constitutive production of multiple colony-stimulating factors in patients with lung cancer associated with neutrophilia.

Authors:  N Adachi; K Yamaguchi; T Morikawa; M Suzuki; I Matsuda; M K Abe
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

6.  Murine tumor cells metastasizing selectively in the liver: ability to produce hepatocyte-activating cytokines interleukin-1 and/or -6.

Authors:  K Takeda; N Fujii; Y Nitta; H Sakihara; K Nakayama; H Rikiishi; K Kumagai
Journal:  Jpn J Cancer Res       Date:  1991-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.